Simplex Trading’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $125 | Buy |
+100
| New | +$211 | ﹤0.01% | 9056 |
|
|
2025
Q4 | – | Sell |
-200
| Closed | -$7K | – | 10478 |
|
|
2025
Q3 | $7K | Buy |
+200
| New | +$5.69K | ﹤0.01% | 8148 |
|
|
2025
Q1 | – | Sell |
-133
| Closed | -$2K | – | 9947 |
|
|
2024
Q4 | $2K | Buy |
+133
| New | +$1.45K | ﹤0.01% | 8116 |
|
|
2023
Q1 | – | Sell |
-225
| Closed | -$86K | – | 10349 |
|
|
2022
Q4 | $86K | Buy |
225
+44
| +24% | +$16.7K | ﹤0.01% | 5265 |
|
|
2022
Q3 | $60K | Buy |
181
+37
| +26% | +$13.4K | ﹤0.01% | 6199 |
|
|
2022
Q2 | $47K | Sell |
144
-23
| -14% | -$8.07K | ﹤0.01% | 6598 |
|
|
2022
Q1 | $72K | Sell |
167
-61
| -27% | -$25K | ﹤0.01% | 6626 |
|
|
2021
Q4 | $99K | Buy |
228
+86
| +61% | +$43.2K | ﹤0.01% | 6267 |
|
|
2021
Q3 | $73K | Buy |
142
+3
| +2% | +$1.5K | ﹤0.01% | 7048 |
|
|
2021
Q2 | $71K | Buy |
139
+131
| +1,638% | +$83K | ﹤0.01% | 7201 |
|
|
2021
Q1 | $605K | Buy |
8
+6
| +300% | +$4.11K | ﹤0.01% | 3099 |
|
|
2020
Q4 | $92K | Hold |
2
| – | – | ﹤0.01% | 5527 |
|
|
2020
Q3 | $90K | Sell |
2
-4
| -67% | -$2.32K | ﹤0.01% | 5025 |
|
|
2020
Q2 | $338K | Sell |
6
-2
| -25% | -$1.1K | ﹤0.01% | 3384 |
|
|
2020
Q1 | $359K | Buy |
8
+1
| +14% | +$543 | ﹤0.01% | 2949 |
|
|
2019
Q4 | $389K | Buy |
7
+1
| +17% | +$702 | ﹤0.01% | 3002 |
|
|
2019
Q3 | $424K | Sell |
6
-2
| -25% | -$1.66K | ﹤0.01% | 2780 |
|
|
2019
Q2 | $645K | Buy |
8
+2
| +33% | +$1.4K | ﹤0.01% | 2341 |
|
|
2019
Q1 | $400K | Buy |
6
+3
| +100% | +$1.8K | ﹤0.01% | 2890 |
|
|
2018
Q4 | $156K | Sell |
3
-1
| -25% | -$645 | ﹤0.01% | 3414 |
|
|
2018
Q3 | $349K | Sell |
4
-17
| -81% | -$12.3K | ﹤0.01% | 3003 |
|
|
2018
Q2 | $1.46M | Buy |
21
+19
| +950% | +$9.7K | 0.01% | 1417 |
|
|
2018
Q1 | $13K | Sell |
2
-6
| -75% | -$2.91K | ﹤0.01% | 3813 |
|
|
2017
Q4 | $73K | Buy |
8
+3
| +60% | +$1.37K | ﹤0.01% | 2080 |
|
|
2017
Q3 | $37K | Sell |
5
-37
| -88% | -$18.5K | ﹤0.01% | 2581 |
|
|
2017
Q2 | $272K | Buy |
42
+24
| +133% | +$15.2K | 0.01% | 1006 |
|
|
2017
Q1 | $55K | Buy |
18
+16
| +800% | +$8.55K | ﹤0.01% | 2270 |
|
|
2016
Q4 | $5K | Hold |
2
| – | – | ﹤0.01% | 4411 |
|
|
2016
Q3 | $3K | Buy |
2
+1
| +100% | +$217 | ﹤0.01% | 4757 |
|
|
2016
Q2 | $3K | Sell |
1
-2
| -67% | -$435 | ﹤0.01% | 4726 |
|
|
2016
Q1 | $2K | Buy |
+3
| New | +$896 | ﹤0.01% | 4842 |
|
|
2015
Q4 | – | Hold |
0
| – | -$3K | – | 6278 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$669 | – | 4442 |
|
|
2015
Q2 | $1K | Buy |
+1
| New | +$386 | ﹤0.01% | 4835 |
|
Other funds holding TVRD
NFL
Simplex Trading's TVRD Position: Q3 2026 in Review
Simplex Trading opened a new position in Tvardi Therapeutics (TVRD) in Q3 2026: 36 shares worth $45. The stake represents ﹤0.01% of the portfolio and ranks #9089 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TVRD as recently as Q4 2025.
Simplex Trading first reported a position in TVRD in Q1 2016 and has held it in 32 quarters since. The position peaked at $447K in Q3 2018. 11 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.
- Simplex Trading held 36 shares of Tvardi Therapeutics worth $45 as of Q3 2026.
- Tvardi Therapeutics was a new Simplex Trading position in Q3 2026.
- Tvardi Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #9089 holding.
- Simplex Trading first reported a position in Tvardi Therapeutics in Q1 2016 and has held it in 32 quarters since.
- Simplex Trading's Tvardi Therapeutics position peaked at $447K in Q3 2018.
- 11 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.